Lynn Lambert
Overview
Explore the profile of Lynn Lambert including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
2070
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Scaria P, Anderson C, Muratova O, Alani N, Trinh H, Nadakal S, et al.
NPJ Vaccines
. 2021 Dec;
6(1):148.
PMID: 34887448
Malaria transmission-blocking vaccines candidates based on Pfs25 and Pfs230 have advanced to clinical studies. Exoprotein A (EPA) conjugate of Pfs25 in Alhydrogel developed functional immunity in humans, with limited durability....
2.
Moraes Barros R, Thawnashom K, Gibson T, Armistead J, Caleon R, Kaneko M, et al.
Malar J
. 2021 Jun;
20(1):247.
PMID: 34090438
Background: Plasmodium knowlesi is now the major cause of human malaria in Malaysia, complicating malaria control efforts that must attend to the elimination of multiple Plasmodium species. Recent advances in...
3.
Conteh S, Kolasny J, Robbins Y, Pyana P, Buscher P, Musgrove J, et al.
Am J Trop Med Hyg
. 2020 Aug;
103(5):1893-1901.
PMID: 32815499
Investigations of malaria infection are often conducted by studying rodent species in inbred laboratory mice, but the efficacy of vaccines or adjunctive therapies observed in these models often does not...
4.
Raj D, Mohapatra A, Jnawali A, Zuromski J, Jha A, Cham-Kpu G, et al.
Nature
. 2020 May;
582(7810):104-108.
PMID: 32427965
Malaria caused by Plasmodium falciparum remains the leading single-agent cause of mortality in children, yet the promise of an effective vaccine has not been fulfilled. Here, using our previously described...
5.
Lambert L, Jamieson P
Future Healthc J
. 2019 Aug;
6(Suppl 1):63.
PMID: 31363586
No abstract available.
6.
Development of a bivalent conjugate vaccine candidate against malaria transmission and typhoid fever
An S, Scaria P, Chen B, Barnafo E, Muratova O, Anderson C, et al.
Vaccine
. 2018 Apr;
36(21):2978-2984.
PMID: 29681410
Immune responses to poorly immunogenic antigens, such as polysaccharides, can be enhanced by conjugation to carriers. Our previous studies indicate that conjugation to Vi polysaccharide of Salmonella Typhi may also...
7.
Scaria P, Chen B, Rowe C, Jones D, Barnafo E, Fischer E, et al.
PLoS One
. 2017 Dec;
12(12):e0190312.
PMID: 29281708
Chemical conjugation of polysaccharide to carrier proteins has been a successful strategy to generate potent vaccines against bacterial pathogens. We developed a similar approach for poorly immunogenic malaria protein antigens....
8.
Collins T, Lambert L, Helms C, Minichiello V
Nurs Educ Perspect
. 2017 Dec;
38(2):98-99.
PMID: 29194307
Simulation is a teaching strategy that allows students to experience patient care situations in a safe environment. After these experiences, students will understand and respond more readily when exposed in...
9.
Zaidi I, Diallo H, Conteh S, Robbins Y, Kolasny J, Orr-Gonzalez S, et al.
J Immunol
. 2017 Oct;
199(11):3781-3788.
PMID: 29079696
Whole-sporozoite vaccines confer sterilizing immunity to malaria-naive individuals by unknown mechanisms. In the first PfSPZ Vaccine trial ever in a malaria-endemic population, Vδ2 γδ T cells were significantly elevated and...
10.
Zhu D, Wu Y, McClellan H, Dai W, Rausch K, Jones D, et al.
Vaccine
. 2017 May;
35(24):3232-3238.
PMID: 28479180
Pfs25, a Plasmodium falciparum surface protein expressed during zygote and ookinete stages in infected mosquitoes, is a lead transmission-blocking vaccine candidate against falciparum malaria. To enhance immunogenicity, recombinant Pfs25 was...